Illumina Announces MiSeq(TM) Personal Sequencing System
January 11, 2011
Delivers Next-Generation Sequencing to Individual Researchers SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced MiSeq(TM), a low-cost personal sequencing system that provides individual researchers a platform with rapid turnaround time, unmatched accuracy, and radically improved ease of use. Leveraging the company's TruSeq(TM) sequencing chemistry, the system's revolutionary workflow offers the flexibility to go from purified [...]
January 11, 2011
GILBERTSVILLE, Pa.--Rockland Immunochemicals Inc., (www.rockland-inc.com) a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies “Biosimilars” for the Treatment of Cancer. [...]
Photon Control Proudly Releases New High Sensitivity UV to NIR Spectrometer to Successful Line Up
January 11, 2011
Burnaby, B.C. - Photon Control Inc. ("Photon Control") (TSX-V: PHO), a leading developer of innovative measurement technologies, is pleased to announce the release of the New SPM-002-XT64 to Photon Control’s successful line up of Spectrometers. The SPM-002-XT64 is now the most versatile spectrometer optical bench in the Photon Control product line. It is equipped with [...]
Beckman Coulter Releases 2011 Cellular Analysis eCatalog on www.coulterflow.com
January 11, 2011
Dynamic Platform Simplifies Lab Management and Product Selection ORANGE COUNTY, CALIF. - Beckman Coulter, Inc. announces the release of its 2011 Cellular Analysis eCatalog, which combines with www.coulterflow.com to provide a comprehensive, adaptable and eco-friendly resource that simplifies the reagent and instrument selection process and improves day-to-day management of a lab’s experiments and needs. This [...]
EyeSense Attracts QIAGEN as Strategic Investor
January 11, 2011
BASEL, Switzerland - EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it has entered into a strategic partnership with QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA). Capitalizing on QIAGEN's ESE fluorescence-based optical technology and on Eyesense's glucose sensing technology, the partners intend to develop [...]
Hach Announces HQd Benchtop Laboratory Meter and Ammonia Ion Selective Electrode Probe
January 11, 2011
Hach further expands its comprehensive line of HQd digital meters and plug-and-play IntelliCAL™ probes Loveland, Colo. - Hach Company (www.hach.com) announces the expansion of its electrochemistry offering with the new HQd Benchtop meter and IntelliCAL™ ammonia ion selective electrode (ISE) probe. Designed to accurately test water quality, the Hach HQd benchtop meter and ammonia probe [...]
Agilent Technologies Secures Patent for Porous Shell LC Particle Manufacturing Technology
January 11, 2011
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a U.S. patent for the process used to apply the superficially porous shell to particles in Agilent Poroshell 120 high-performance liquid chromatography (HPLC) columns. The patent was issued for the unique coacervation process used to manufacture the Poroshell 120 silica. [...]
New Genedata Screener Presented at CHI High Content Analysis Conference
January 11, 2011
Screener 9 delivers an enterprise hub for HCS data, linking multiple instruments and image management systems to create cost efficiencies and improved productivity San Francisco, Calif. - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a new version of Genedata Screener®, a comprehensive software system for [...]
January 11, 2011
Germantown, MD., and Hilden, Germany - QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has signed an agreement for the acquisition of a strategic stake in Alacris Theranostics GmbH, a German start-up company using novel technologies to develop individualized cancer treatment strategies based upon a patient's genomic profile, and for the acquisition of an exclusive option [...]
StemCells, Inc. Closes $10 Million Common Stock Financing
January 11, 2011
PALO ALTO, Calif. - StemCells, Inc. (Nasdaq:STEM) announced today that it has closed the sale of 10 million shares of common stock, at a fixed price of $1.00 per share. The Company received total proceeds, net of offering expenses and placement agency fees, of approximately $9.4 million. The common stock was sold in a registered [...]

